Eleven Therapeutics Raises $22m Series Seed
In the News
2/8/2022
London, UK
Round includes $9 Million from the Bill & Melinda Gates Foundation, aimed at ushering in the next generation of RNAi therapeutics
https://medium.com/@eleventx/eleven-therapeutics-announces-22-million-in-seed-funding-7a51cbc1bce7
Related Resources
Blog
06.08.2026
Autonomous Infrastructure Efficiency
Why did we back (and are continuing to back) PointFive?
Blog
02.14.2026
Guidde: The AI-native horizontal PLG startup that could
From Chrome Extension to Enterprise Platform: Guidde’s Masterclass in Product-Led Growth
Blog
02.11.2026
The SaaS Reckoning: Surviving the AI Token Revolution
Public SaaS faces a structural reckoning as valuations plunge while the market demands autonomous execution. To survive this "Fork in the Road," incumbents must evolve from mere Systems of Record into Systems of Context. By moving beyond organizing work to actually completing it, software can finally bridge the AI value gap.